Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2018 Nov 24;25(4):791–799. doi: 10.1016/j.bbmt.2018.11.012

Figure 5.

Figure 5.

6-month overall survival (OS) at after HCT by CMV viremia.

OS was similar for CONV with and without CMV viremia (P = 0.53) (left panel) and CD34-selected with and without CMV viremia (P = 0.14) (right panel).